Moderna

Associate Director, Field Medical Advisor (m/w/d)

Germany

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Position Overview

  • Location Type: Germany (Onsite)
  • Employment Type: Full-time
  • Job Type: Field Medical Advisor
  • Company: Moderna

Description: Moderna offers a unique opportunity to join a pioneering team revolutionizing medicine through mRNA technology. As a Field Medical Advisor in Germany, you’ll be a crucial link between Moderna and the medical community, establishing relationships with healthcare practitioners, policy makers, and patient groups. You’ll focus on improving patient outcomes by sharing the science behind Moderna’s mRNA platform through peer-to-peer scientific exchange, driving forward Moderna’s mission to deliver cutting-edge mRNA-based therapies and vaccines. This role demands a combination of scientific expertise, strategic thinking, and ethical engagement.

Requirements

  • Strong scientific background (details not provided)
  • Excellent communication and interpersonal skills
  • Ability to explain complex scientific topics to diverse audiences
  • Strategic thinking and problem-solving skills
  • Ethical engagement and professionalism

Responsibilities

  • Developing and implementing tailored Scientific Engagement Plans.
  • Utilizing Moderna’s Scientific Communications Platform and generative AI to share Moderna’s scientific messages.
  • Generating medical insights to understand key trends and stakeholder dynamics.
  • Engaging with Key Opinion Leaders, scientific societies, and patient advocacy groups.
  • Sharing up-to-date scientific narratives and data across Moderna’s therapeutic areas.
  • Collaborating with healthcare professionals to identify and address unmet patient needs.
  • Leading and executing medical engagement activities.

Application Instructions

  • (Details not provided – further information needed)

Company Information

  • Company: Moderna
  • Focus: Advancing the development and delivery of mRNA-based medicines and vaccines in Germany.
  • Mission: To deliver cutting-edge mRNA-based therapies and vaccines.
  • Location: Germany
  • Industry: Pharmaceutical Innovation

Skills

Scientific expertise
Communication skills
Interpersonal skills
Scientific explanation
Strategic thinking
Problem-solving
Ethical engagement

Moderna

Develops mRNA-based medicines for health

About Moderna

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
401(k) Company Match
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend

Risks

Potential backlash in Australia for bypassing vaccine safety steps.
Possible removal from Nasdaq 100 Index could affect investor confidence.
Hong Kong residents' reluctance to get vaccinated may hinder market penetration.

Differentiation

Moderna is pioneering mRNA technology for new categories of medicines.
The company integrates AI to optimize mRNA design and production processes.
Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Upsides

Moderna received a $176 million contract for a bird flu vaccine.
The company is expanding mRNA applications to personalized cancer vaccines.
Moderna is establishing a domestic mRNA production facility in Australia.

Land your dream remote job 3x faster with AI